000 | 01279 a2200337 4500 | ||
---|---|---|---|
005 | 20250517163019.0 | ||
264 | 0 | _c20180510 | |
008 | 201805s 0 0 eng d | ||
022 | _a1096-1186 | ||
024 | 7 |
_a10.1016/j.phrs.2017.07.006 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPulluri, Bhargavi | |
245 | 0 | 0 |
_aTumor microenvironment changes leading to resistance of immune checkpoint inhibitors in metastatic melanoma and strategies to overcome resistance. _h[electronic resource] |
260 |
_bPharmacological research _cSep 2017 |
||
300 |
_a95-102 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aDrug Resistance, Neoplasm |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunotherapy |
650 | 0 | 4 |
_aMelanoma _xdrug therapy |
650 | 0 | 4 |
_aMitogen-Activated Protein Kinase Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aProto-Oncogene Proteins B-raf _xantagonists & inhibitors |
650 | 0 | 4 | _aTumor Microenvironment |
700 | 1 | _aKumar, Abhijeet | |
700 | 1 | _aShaheen, Montaser | |
700 | 1 | _aJeter, Joanne | |
700 | 1 | _aSundararajan, Srinath | |
773 | 0 |
_tPharmacological research _gvol. 123 _gp. 95-102 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.phrs.2017.07.006 _zAvailable from publisher's website |
999 |
_c27350625 _d27350625 |